Pharmacoepidemiology, impacts of anxiety disorders and anxiolytic abuse before and during the COVID-19 pandemic. RSD [Internet]. 2022 Apr. 9 [cited 2025 Dec. 6];11(5):e36111528340. Available from: https://rsdjournal.org/rsd/article/view/28340